¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø, ¼¼°è ¹× Áö¿ªº° Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® ¸®Æ÷Æ® ¹üÀ§ : Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Vital Signs Monitoring Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography
»óǰÄÚµå : 1372495
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2023³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 223 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,450 £Ü 6,126,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 6,450 £Ü 8,879,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,450 £Ü 11,633,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2022³â¿¡ 256¾ï 1,700¸¸ ´Þ·¯, 2030³â¿¡´Â 668¾ï 2,400¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Ãß»êµÇµÇ¸ç, 2022-2030³âÀÇ CAGRÀº 12.7%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº Á¦Ç° Ãâ½Ã ¹× ½ÂÀÎ ¼ö Áõ°¡, ȯÀÚµéÀÇ ¿ø°Ý ¸ð´ÏÅ͸µ ¼ö¿ä Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ±×·¯³ª ±â¾÷ ¹× ±ÔÁ¦ ´ç±¹ÀÇ Á¦Ç° ȸ¼ö Á¶Ä¡°¡ ½ÃÀå ¼ºÀåÀÇ °É¸²µ¹·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡

»ýü ½ÅÈ£ ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä´Â COVID-19°¡ À¯ÇàÇÒ ¶§ ±Þ°ÝÇÏ°Ô ±ÞÁõÇß½À´Ï´Ù. ¶ÇÇÑ COVID-19 ÆÒµ¥¹Í ±â°£ Áß ¸ÞµðÄÉ¾î ¾îµå¹êƼÁö(Medicare Advantage) û±¸°¡ ±ÞÁõÇߴµ¥, 2022³â 9¿ù Health AffairsÁö¿¡ °ÔÀçµÈ ¿¬±¸¿¡ µû¸£¸é COVID-19 ÆÒµ¥¹Í ±â°£ Áß ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ û±¸ °Ç¼ö°¡ 4¹è Áõ°¡ÇÏ¿© 2020³â 3¿ù 4, 355°Ç¿¡¼­ 2021³â 3¿ù 19,762°ÇÀ¸·Î Áõ°¡Çß½À´Ï´Ù. 355°Ç¿¡¼­ 2021³â 3¿ù¿¡´Â 19,762°Ç¿¡ ´ÞÇß½À´Ï´Ù. ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀº ȯÀÚÀÇ È°·Â ¡Èĸ¦ ¸ð´ÏÅ͸µÇÏ´Â ÀüÅëÀûÀÎ ¹æ¹ýÀ» ´ëüÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ °Ç°­ÀÇ º¸±ÞÀº ÀçÅÃÄ¡·á ¼­ºñ½º Áõ°¡·Î À̾îÁ® ÀçÅÃÄ¡·á ÇöÀå¿¡¼­ ÆÞ½º¿Á½Ã¹ÌÅÍ, Ç÷¾Ð°è, ü¿Â°è µîÀÇ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. Áö³­ ¼ö³â°£ ÀçÅÃÄ¡·á´Â ¼¼°è ÀÇ·á ½Ã½ºÅÛÀÇ È¿À²¼º°ú ºñ¿ë È¿À²¼ºÀ» Çâ»ó½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ³ëÀÎ Àα¸¿Í º´¿ø Ä¡·á ÈÄ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ ÁßÁõ ȯÀÚµéÀ» À§ÇÑ ÀçÅÃÄ¡·á ȯ°æ¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¹«¼± ±â¼ú°ú ¿þ¾î·¯ºí ±â±â µîÀÇ ¹ßÀüÀ¸·Î ÀÇ·áÁø °£ »óÈ£¿î¿ë¼º°ú ȯÀÚ °£ È®À强ÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â±âµéÀº ½ÉÀå »óÅÂ, üÁß º¯È­, Ç÷¾Ð, ¼ö¸é¹«È£ÈíÁõ, õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ µîÀ» ½±°Ô ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ COVID-19 À§±â µ¿¾È ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ º¯È­Çϸ鼭 ¿ø°Ý Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ ÀåºñÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ »ç¿ëÀº º´¿ø ¹æ¹® ºóµµ¸¦ Å©°Ô °¨¼Ò½ÃÄÑ ÀÇ·á ÀÚ¿ø Ȱ¿ëÀ» ÃÖÀûÈ­Çϰí ÀǷḦ º¸´Ù Áö¼Ó°¡´ÉÇÏ°Ô ¸¸µé¾ú½À´Ï´Ù. ¶ÇÇÑ ¼Ò¼È¹Ìµð¾îÀÇ ¿µÇâ°ú ÀÇ·á ½Ã¼³ÀÇ È£ÀÇÀûÀÎ ³ë·ÂÀ¸·Î ÀÎÇØ Áö¹æ°ú µµ½Ã Áö¿ª »ç¶÷µéÀÌ ¿ø°ÝÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³½À´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÎ¹®º° °³¿ä

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀº Á¦Ç° ¹× ÃÖÁ¾»ç¿ëÀÚº°·Î ºÐ¼®µË´Ï´Ù. Á¦Ç° ±âÁØÀ¸·Î´Â ÆÞ½º¿Á½Ã¹ÌÅÍ, Ç÷¾Ð ¸ð´ÏÅÍ, ü¿Â ¸ð´ÏÅÍ, Ç÷´ç ¸ð´ÏÅ͸µ ±â±â·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â Æ÷µµ´ç ¸ð´ÏÅÍ ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí 2022-2030³â¿¡´Â ÆÞ½º¿Á½Ã¹ÌÅÍ ºÎ¹®ÀÌ °¡Àå ºü¸¥ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ÆÞ½º¿Á½Ã¹ÌÅʹ Ź»óÇü/Ãø¸éÇü ÆÞ½º¿Á½Ã¹ÌÅÍ, ÈÞ´ë¿ë ÆÞ½º¿Á½Ã¹ÌÅÍ, ÆÞ½º¿Á½Ã¹ÌÅÍ ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ¸¶Âù°¡Áö·Î Ç÷¾Ð°è ºÎ¹®Àº ¼öÀº Ç÷¾Ð°è, ¿Ü·¡ Ç÷¾Ð°è, µðÁöÅÐ Ç÷¾Ð°è, ¾Æ³¯·Î±× Ç÷¾Ð°è, Ç÷¾Ð°è ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ¸¶Âù°¡Áö·Î ü¿Â ¸ð´ÏÅ͸µ Àåºñ ºÎ¹®Àº ¼öÀº ÃæÀü ¿Âµµ°è, µðÁöÅÐ ¿Âµµ°è, Àû¿Ü¼± ¿Âµµ°è, ¾×Á¤ ¿Âµµ°è, ü¿Â ¸ð´ÏÅ͸µ Àåºñ ¾×¼¼¼­¸®·Î ¼¼ºÐÈ­µË´Ï´Ù. ¶ÇÇÑ Æ÷µµ´ç ¸ð´ÏÅÍ´Â ÀÚ°¡ Æ÷µµ´ç ¸ð´ÏÅÍ¿Í ¿¬¼Ó Æ÷µµ´ç ¸ð´ÏÅÍ·Î ¼¼ºÐÈ­µË´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â º´¿ø ¹× Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á, ±âŸ·Î ºÐ·ùµÇ¸ç, 2022³â¿¡´Â º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀçÅÃÄ¡·á ºÐ¾ß´Â 2022-2030³â °¡Àå ºü¸¥ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð Áõ°¡, ÀçÅÃÄ¡·á ȯ°æ¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡, ÀÇ·á±â±â ¿¬±¸ ¹× °³¹ß Áõ°¡´Â Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ Àåºñ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå Áö¿ªº° °³¿ä

Áö¿ªº°·Î´Â ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀ» ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«, Áß³²¹Ì·Î ³ª´©¾î ºÐ¼®Çϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â ºÏ¹Ì°¡ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀåÀÇ ÃÖ´ë ½ÃÀåÀ̸ç, À¯·´ÀÌ ±Þ¼ºÀå Áö¿ªÀÔ´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ÁÖ¿ä ±â¾÷

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¶»ç¿¡¼­´Â Koninklijke Philips NV, Medtronic Plc, ´ÏÈ¥ÄÚµ§»ê¾÷, GE HealthCare Technologies Inc, OMRON Corp, Nonin Medical Inc, SunTech Medical Inc, Masimo Corp, Contec Medical Systems Co Ltd, Baxter International Inc. µîÀÇ ÁÖ¿ä ±â¾÷ÀÌ ºÐ¼® µÇ¾ú½À´Ï´Ù.

¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡ °üÇÑ ¸®Æ÷Æ® ÀÛ¼º½Ã ÂüÁ¶ÇÑ ÁÖ¿ä 1Â÷ Á¤º¸¿Í 2Â÷ Á¤º¸¿¡´Â ¼¼°èº¸°Ç±â±¸(WHO), FDA(½ÄǰÀǾ౹), µ¶ÀÏ ¿¬¹æ ±³À° ¿¬±¸¼º, ±¹Á¦´ç´¢º´¿¬¸Í(IDF) µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ±¸µµ

Á¦5Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÁÖ¿ä »ê¾÷ ¿ªÇÐ

Á¦6Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ¼¼°è ½ÃÀå ºÐ¼®

Á¦7Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå - 2030³â±îÁöÀÇ ¸ÅÃâ°ú ¿¹Ãø : Á¦Ç°º°

Á¦8Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº° ¸ÅÃâ°ú 2030³â±îÁöÀÇ ¿¹Ãø

Á¦9Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå - Áö¿ª ºÐ¼®

Á¦10Àå COVID-19 ÀüÈÄÀÇ ¿µÇâ

Á¦11Àå ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅÍ ½ÃÀå - ¾÷°è »óȲ

Á¦12Àå ±â¾÷ °³¿ä

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The vital signs monitoring devices market is estimated to reach US$ 25.617 billion in 2022 to US$ 66.824 billion by 2030; the market is projected to record a CAGR of 12.7% from 2022 to 2030.

Some of the key driving factors for the vital signs monitoring devices market growth are the increasing number of product launches and approvals and rise in need for remote patient monitoring. However, product recalls by companies and regulatory authorities are hindering market growth.

Rise in Need for Remote Patient Monitoring

The demand for vital signs monitoring devices surged exponentially during the COVID-19 pandemic. Moreover, there was a sudden increase in Medicare Advantage claims during the COVID-19 pandemic. As per a survey published in Health Affairs in September 2022, claims for remote patient monitoring grew by four times during the COVID-19 pandemic, reaching 19,762 claims in March 2021 from 4,355 claims in March 2020. Remote patient monitoring has replaced conventional methods of monitoring patients' vital signs. The popularity of digital health has led to a rise in home care services, creating tremendous demand for devices such as pulse oximeters, BP monitors, and thermometers in homecare settings. Home healthcare has led to enhanced efficiency and cost-effectiveness in healthcare systems worldwide in the last few years. Similarly, the demand for remote patient monitoring increases with the growing preference for home care settings for the geriatric population and for people with critical conditions who require monitoring post-hospital care.

Advancements such as wireless technologies and wearable devices have improved interoperability among healthcare professionals and scalability among patients. These devices have made it easy to monitor heart conditions, weight gain/loss, blood pressure, sleep apnea, asthma, and chronic obstructive pulmonary disease. In addition, the requirement for remote vital signs monitoring devices grew during the COVID-19 crisis owing to a shift in consumer preference toward telehealth. The use of telehealth resulted in a significant decrease in the frequency of hospital visits and optimized the use of healthcare resources, making healthcare more sustainable. Additionally, people in rural and urban areas are becoming highly aware of telehealth services due to the influence of social media and favorable initiatives by healthcare facilities.

Vital Signs Monitoring Devices Market: Segmental Overview

The vital signs monitoring devices market is analyzed on the product and end user. On the basis product, the market is segmented into pulse oximeter, blood pressure monitors, temperature monitoring devices, and glucose monitoring devices. In 2022, the glucose monitors segment held the largest market share, during 2022-2030 the pulse oximeters segment is anticipated to grow with a fastest growth rate. Further, pulse oximeter is subsegmented into table-top/beside pulse oximeters, hand-held pulse oximeters, and pulse oximeter accessories. Similarly, blood pressure monitors segment is subsegmented into mercury blood pressure monitors, ambulatory blood pressure monitors, digital blood pressure monitors, analog blood pressure monitors, and blood pressure instrument accessories. Likewise, temperature monitoring devices segment is subsegmented into mercury filled thermometers, digital thermometers, infrared thermometers liquid crystal thermometers, and temperature monitoring device accessories. And based on glucose monitors is subsegmeneted into self glucose monitors and continuous glucose monitors.

On the basis of end user, the market is classified into hospitals & clinics, ambulatory surgical centers, home healthcare, and others. In 2022, the hospitals and clinics segment held the largest market share holder. The home healthcare segment is estimated to register the fastest CAGR during 2022-2030. The increasing number of hospitals and clinics, surging preference for home healthcare settings, and rising R&D in medical devices are the key factors contributing to the growth of the vital signs monitoring devices market.

Vital Signs Monitoring Devices Market: Geographical Overview

Based on geography, the vital signs monitoring devices market is analyzed for North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. Based on regions, North America is the largest market for vital signs monitoring devices market, and Europe is the fastest-growing region.

Vital Signs Monitoring Devices Market: Key Players

Under the vital signs monitoring devices market study, a few key players were analyzed, which include Koninklijke Philips NV, Medtronic Plc, Nihon Kohden Corp, GE HealthCare Technologies Inc, OMRON Corp, Nonin Medical Inc, SunTech Medical Inc, Masimo Corp, Contec Medical Systems Co Ltd, and Baxter International Inc.

A few of the key primary and secondary sources referred to while preparing the report on the vital signs monitoring devices market are the World Health Organization (WHO), FDA (Food and Drug Administration), German Federal Ministry of Education and Research, and International Diabetes Federation (IDF).

Reasons to Buy:

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Vital Signs Monitoring Devices Market Landscape

5. Vital Signs Monitoring Devices Market - Key Industry Dynamics

6. Vital Signs Monitoring Devices Market - Global Market Analysis

7. Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 - by Product

8. Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 - by End User

9. Vital Signs Monitoring Devices Market - Regional Analysis

10. Pre & Post Covid-19 Impact

11. Vital Signs Monitoring Devices Market-Industry Landscape

12. Company Profiles

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â